{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T07:37:00Z","timestamp":1768808220602,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.tripleo.2006.10.010","type":"journal-article","created":{"date-parts":[[2007,1,17]],"date-time":"2007-01-17T00:39:38Z","timestamp":1168994378000},"page":"780-786","source":"Crossref","is-referenced-by-count":55,"title":["Osteonecrosis of the jaws associated with use of risedronate: Report of 2 new cases"],"prefix":"10.1016","volume":"103","author":[{"given":"John K.","family":"Brooks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen J.","family":"Gilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold J.","family":"Sindler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven G.","family":"Ashman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin G.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos G.","family":"Nikitakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tripleo.2006.10.010_bib1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","article-title":"Systematic review: bisphosphonates and osteonecrosis of the jaws","volume":"144","author":"Woo","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tripleo.2006.10.010_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/01.ogx.0000197807.08697.06","article-title":"Fracture prevention in postmenopausal osteoporosis: a review of treatment options","volume":"61","author":"McCarus","year":"2006","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.tripleo.2006.10.010_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00296-004-0544-z","article-title":"Comparison of the effects of alendronate and risedronate on bone mineral density and bone turnover markers in postmenopausal osteoporosis","volume":"26","author":"Sarioglu","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.tripleo.2006.10.010_bib4","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/rheumatology\/keh481","article-title":"Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip","volume":"44","author":"Agarwala","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.tripleo.2006.10.010_bib5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2006.10.010_bib6","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2006.10.010_bib7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.oraloncology.2005.08.001","article-title":"Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions","volume":"42","author":"Bagan","year":"2006","journal-title":"Oral Oncol"},{"key":"10.1016\/j.tripleo.2006.10.010_bib8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1365-2141.2005.05833.x","article-title":"Bisphosphonate-associated osteonecrosis of the auditory canal","volume":"132","author":"Polizzotto","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tripleo.2006.10.010_bib9","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/annonc\/mdj105","article-title":"Management of the adverse effects associated with intravenous bisphosphonates","volume":"17","author":"Tanvetyanon","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.tripleo.2006.10.010_bib10","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1200\/JCO.2005.01.7756","article-title":"Case 2","volume":"24","author":"Mignogna","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tripleo.2006.10.010_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Durie","year":"2005","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"10.1016\/j.tripleo.2006.10.010_bib12","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1007\/PL00014039","article-title":"Bisphosphonates for the treatment of postmenopausal osteoporosis: clinical studies of etidronate and alendronate","volume":"12","author":"Harris","year":"2001","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.tripleo.2006.10.010_bib13","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00223-004-0286-7","article-title":"Seven years of treatment with risedronate in women with postmenopausal osteoporosis","volume":"75","author":"Mellstr\u00f6m","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.tripleo.2006.10.010_bib14","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s00198-005-1986-1","article-title":"Prescription-event monitoring study on 13,164 patients prescribed risedronate in primary care in England","volume":"16","author":"Barrera","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.tripleo.2006.10.010_bib15","series-title":"Updated safety: possible relationship of Aredia (pamidronate disodium) and\/or Zometa (zoledronic acid) with osteonecrosis of the jaw","year":"2004"},{"key":"10.1016\/j.tripleo.2006.10.010_bib16","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1111\/j.1834-7819.2005.tb00384.x","article-title":"The dental implications of bisphosphonates and bone disease","volume":"50","author":"Cheng","year":"2005","journal-title":"Aust Dent J"},{"key":"10.1016\/j.tripleo.2006.10.010_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21130","article-title":"Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone","volume":"104","author":"Migliorati","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.tripleo.2006.10.010_bib18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5694\/j.1326-5377.2005.tb06762.x","article-title":"Bisphosphonates and osteonecrosis of the jaw","volume":"182","author":"Purcell","year":"2005","journal-title":"Med J Aust"},{"key":"10.1016\/j.tripleo.2006.10.010_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.mlg.0000187398.51857.3c","article-title":"Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates","volume":"116","author":"Farrugia","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.tripleo.2006.10.010_bib20","first-page":"27","article-title":"Bisphosphonate induced osteonecrosis of the jaw","volume":"2","author":"Kushner","year":"2005","journal-title":"Dialogue"},{"key":"10.1016\/j.tripleo.2006.10.010_bib21","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.14219\/jada.archive.2006.0350","article-title":"Osteonecrosis of the jaw and oral bisphosphonate treatment","volume":"137","author":"Nase","year":"2006","journal-title":"J Am Dent Assoc"},{"issue":"Suppl 1","key":"10.1016\/j.tripleo.2006.10.010_bib22","first-page":"55","article-title":"Osteonecrosis of the jaw in patients receiving intravenous bisphosphonate therapy","volume":"20","author":"Hoff","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.tripleo.2006.10.010_bib23","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/01.don.0000182737.09980.2c","article-title":"Bisphosphonate-associated osteonecrosis of the jaws and endodontic treatment: two case reports","volume":"31","author":"Sarathy","year":"2005","journal-title":"J Endod"},{"key":"10.1016\/j.tripleo.2006.10.010_bib24","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.joms.2006.05.042","article-title":"Bisphosphonate-associated osteonecrosis (BON) of the jaws: a possible treatment?","volume":"64","author":"Vescovi","year":"2006","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2006.10.010_bib25","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/archinte.164.14.1525","article-title":"National trends in osteoporosis visits and osteoporosis treatment, 1988-2003","volume":"164","author":"Stafford","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.tripleo.2006.10.010_bib26","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.14219\/jada.archive.2006.0355","article-title":"Dental management of patients on oral bisphosphonate therapy: expert panel recommendations","volume":"137","year":"2006","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.tripleo.2006.10.010_bib27","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1001\/jama.295.24.2833","article-title":"Reports of adverse events from bone drugs prompt caution","volume":"295","author":"Kuehn","year":"2006","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.tripleo.2006.10.010_bib28","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1016\/j.biomaterials.2003.11.024","article-title":"Osteoblast proliferation and maturation by bisphosphonates","volume":"25","author":"Im","year":"2004","journal-title":"Biomaterials"},{"key":"10.1016\/j.tripleo.2006.10.010_bib29","first-page":"6538","article-title":"Bisphosphonates inhibit angiogenesis in Vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats","volume":"62","author":"Fournier","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.tripleo.2006.10.010_bib30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0714.2006.00391.x","article-title":"Osteonecrosis of the jaws in patients treated with bisphosphonates\u2014histomorphologic analysis in comparison with infected osteoradionecrosis","volume":"35","author":"Hansen","year":"2006","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.tripleo.2006.10.010_bib31","first-page":"713","article-title":"Clinical and histologic evaluation of an active \u201cimplant periapical lesion\u201d: a case report","volume":"13","author":"Piattelli","year":"1998","journal-title":"Int J Oral Maxillofac Implants"},{"key":"10.1016\/j.tripleo.2006.10.010_bib32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1601-0825.2005.01130.x","article-title":"Oral avascular bone necrosis associated with chemotherapy and biphosphonate therapy","volume":"11","author":"Pires","year":"2005","journal-title":"Oral Dis"},{"key":"10.1016\/j.tripleo.2006.10.010_bib33","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s100670200078","article-title":"Risk period for developing osteonecrosis of the femoral head in patients on steroid treatment","volume":"21","author":"Koo","year":"2002","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.tripleo.2006.10.010_bib34","series-title":"Oral and maxillofacial pathology","first-page":"276","article-title":"Physical and chemical injuries","year":"2002"},{"key":"10.1016\/j.tripleo.2006.10.010_bib35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1834-7819.2003.tb00011.x","article-title":"Oral ulceration with bone sequestration","volume":"48","author":"Farah","year":"2003","journal-title":"Aust Dent J"},{"key":"10.1016\/j.tripleo.2006.10.010_bib36","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/oxfordjournals.aje.a116706","article-title":"Association of alcohol intake, cigarette smoking, and occupational status with the risk of idiopathic osteonecrosis of the femoral head","volume":"137","author":"Hirota","year":"1993","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.tripleo.2006.10.010_bib37","series-title":"America\u2019s bone health: the state of osteoporosis and low bone mass in our nation","year":"2002"},{"key":"10.1016\/j.tripleo.2006.10.010_bib38","first-page":"26","article-title":"Top 200 brand-name drugs by retail dollars in 2005","volume":"150","year":"2006","journal-title":"Drug Topics"},{"key":"10.1016\/j.tripleo.2006.10.010_bib39","first-page":"18","article-title":"Pharmacokinetics of alendronate: an overview","volume":"101","author":"Lin","year":"1999","journal-title":"Int J Clin Pract Suppl"},{"key":"10.1016\/j.tripleo.2006.10.010_bib40","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1470-2045(06)70726-4","article-title":"Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment","volume":"7","author":"Migliorati","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.tripleo.2006.10.010_bib41","first-page":"349","article-title":"Safety of oral bisphosphonates: controlled studies on alveolar bone","volume":"21","author":"Jeffcoat","year":"2006","journal-title":"Int J Oral Maxillofac Implants"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210406008110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210406008110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T19:25:02Z","timestamp":1587324302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079210406008110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S1079210406008110"],"URL":"https:\/\/doi.org\/10.1016\/j.tripleo.2006.10.010","relation":{},"ISSN":["1079-2104"],"issn-type":[{"value":"1079-2104","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}